Streetbeat News

Revenues

BLBD

Blue Bird has raised its FY24 guidance for net revenue from the previous range of $1.275 billion - $1.325 billion to a new range of $1.30 billion - $1.33 billion, with an estimated $1.318 billion.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:29 pm

SITM

SiTime (NASDAQ:SITM) reported Q2 2024 adjusted EPS of $0.12, beating the $0.04 estimate by 200%. Sales were $43.866M, surpassing the $41.005M estimate by 6.98% and marking a 58.20% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:28 pm

KRMD

KORU Medical Systems (NASDAQ:KRMD) reported Q2 2024 adjusted EPS of $(0.01), beating the $(0.04) estimate, and sales of $8.430M, surpassing the $7.570M estimate. This represents a 75% improvement in EPS and a 21.54% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:28 pm

CURLF

Curaleaf Holdings reported Q2 2024 GAAP EPS of $(0.06), meeting analyst expectations, but missed sales estimates with $342.286M, a slight increase from last year's $338.580M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:28 pm

CLPT

ClearPoint Neuro (CLPT) has provided its revenue guidance for FY24, projecting revenues between $30M and $33M, which is in line with the current estimate of $30.52M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:28 pm

PAM

Pampa Energia (NYSE:PAM) reported Q2 2024 GAAP EPS of $1.80, beating the $0.95 estimate by 89.47%. However, sales of $500 million missed the $518.27 million estimate by 3.53%, though they increased by 7.76% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:27 pm

BLBD

Blue Bird has raised its long-term profit outlook, targeting an adjusted EBITDA margin of 15% on approximately $2 billion in revenues.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:27 pm

Z

ZG

Zillow Group Inc (NASDAQ:Z) (NASDAQ:ZG) reported strong Q2 earnings, beating revenue and EPS estimates. The company announced a new CEO and provided strong guidance for Q3. Revenue increased across all segments, and the company expects continued growth.

Portfolio Pulse from Adam Eckert

August 07, 2024 | 9:26 pm

BDSX

Biodesix has announced its FY24 revenue forecast to be between $70 million and $72 million, surpassing the previous estimate of $66.98 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:26 pm

ALNT

Allient expects its annualized revenue run rate to be below $500M over the next several quarters, with a return to normal run rates anticipated by mid-2025. The company also projects $5M in annual savings from manufacturing consolidation and streamlining efforts starting in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:25 pm